CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Stock Information for OraSure Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About OraSure Technologies Inc.

OraSure Reports Fourth Quarter 2024 Financial Results
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
OraSure to Present at the J.P Morgan Healthcare Conference
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
OraSure Technologies Acquires Sherlock Biosciences
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
OraSure to Participate in Upcoming Investor Conference
OraSure Reports Q3 '24 Revenue of $39.9 Million

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.